Therapeutic benefits of glutamine: An umbrella review of meta-analyses

McRae,Marc  P.

doi:10.3892/br.2017.885

Therapeutic benefits of glutamine: An umbrella review of meta-analyses

Authors:
- Marc P. McRae
View Affiliations

Affiliations: Department of Basic Science, National University of Health Sciences, Lombard, IL 60148, USA
Published online on: April 5, 2017 https://doi.org/10.3892/br.2017.885
Pages: 576-584

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glutamine may be an essential amino acid in patients with catabolic disease, as it has been demonstrated that circulating glutamine levels drop during critical illness and following major surgery; this may result in an increase in secondary infection risk, recovery time and mortality rates. However, there is much discrepancy in the literature with regards to randomized controlled studies, and therefore, the present study is an umbrella review of published meta‑analyses, conducted to examine the effectiveness of glutamine's role as a therapeutic agent. A search using PubMed, Cochrane Library and CINAHL from January 1st, 1980 to December 31st, 2016 was conducted using the following strategy: ‘Glutamine AND (meta‑analysis OR systematic review)’ and publications were retrieved, which provided quantitative statistical analysis of pooled treatment effects on the relative risks of infectious complications, mortality and length of stay in hospital. A total of 22 meta‑analyses were entered into the current umbrella review. As displayed in Tables I, II and III, these analyses are split into three groups, based on different parameters. Of the 19 meta‑analyses investigating the effects of infectious complications, 15 identified statistically significant reductions in complications, with relative risks ranging between 0.42 and 0.93. In addition, 12 of the 18 meta‑analyses analyzing the length of hospital stays presented statistically significant reductions in the length of stay, with reductions ranging between 0.19 to 4.73 days. Only 4 of the 15 meta‑analyses studying mortality effects identified statistically significant reductions in mortality with relative risks ranging between 0.64 and 1.28. Statistically significant heterogeneity was observed in 16 of 22 meta‑analyses, and publication bias was observed in five of 11 meta‑analyses. Glutamine supplementation for critically ill or surgical patients through parenteral or enteral routes appears to reduce the rate of hospital acquired infectious complications and shortening of the length of stay in hospital. Furthermore, glutamine supplementation appeared to reduce the rate of in‑patient mortality, but the majority of meta-analyses did not reach statistical significance. However, researchers must appreciate the positive results with caution in light of the fact that there exists statistically significant heterogeneity for the majority of meta-analyses, and statistically significant publication bias in almost half.

View Figures

View References

1	Wischmeyer PE: Glutamine: Mode of action in critical illness. Crit Care Med. 35 Suppl 9:S541–S544. 2007. View Article : Google Scholar : PubMed/NCBI
2	Wischmeyer PE: Glutamine: Role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol. 24:190–197. 2008. View Article : Google Scholar : PubMed/NCBI
3	Wischmeyer PE: Glutamine: Role in gut protection in critical illness. Curr Opin Clin Nutr Metab Care. 9:607–612. 2006. View Article : Google Scholar : PubMed/NCBI
4	van Zanten AR: Glutamine and antioxidants: Status of their use in critical illness. Curr Opin Clin Nutr Metab Care. 18:179–186. 2015. View Article : Google Scholar : PubMed/NCBI
5	Cynober L and De Bandt JP: Glutamine in the intensive care unit. Curr Opin Clin Nutr Metab Care. 17:98–104. 2014.PubMed/NCBI
6	Mundi MS, Shah M and Hurt RT: When is it appropriate to use glutamine in critical illness? Nutr Clin Pract. 31:445–450. 2016. View Article : Google Scholar : PubMed/NCBI
7	Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H and Tungpunkom P: Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 13:132–140. 2015. View Article : Google Scholar : PubMed/NCBI
8	Jiang ZM and Jiang H: The clinical efficacy of glutamine dipeptides on postoperative patients: An updated systematic review of randomized controlled trials from Europe and Asia (1997–2005). Zhonghua Yi Xue Za Zhi. 86:1610–1614. 2006.(In Chinese). PubMed/NCBI
9	Jiang H, Chen W, Hu W, Cai B and Liao RJ: The impact of glutamine-enhanced enteral nutrition on clinical outcome of patients with critical illness: A systematic review of randomized controlled trials. Zhonghua Shao Shang Za Zhi. 25:325–330. 2009.(In Chinese). PubMed/NCBI
10	Moe-Byrne T, Brown JV and McGuire W: Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 4:CD0014572016.PubMed/NCBI
11	Castro-Gutiérrez V and Rada G: Is there a role for glutamine supplementation in the management of acute pancreatitis? Medwave. 16(Suppl 3): e65122016. View Article : Google Scholar : PubMed/NCBI
12	Novak F, Heyland DK, Avenell A, Drover JW and Su X: Glutamine supplementation in serious illness: A systematic review of the evidence. Crit Care Med. 30:2022–2029. 2002. View Article : Google Scholar : PubMed/NCBI
13	Avenell A: Glutamine in critical care: Current evidence from systematic reviews. Proc Nutr Soc. 65:236–241. 2006. View Article : Google Scholar : PubMed/NCBI
14	Avenell A: Hot topics in parenteral nutrition. Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery. Proc Nutr Soc. 68:261–268. 2009. View Article : Google Scholar : PubMed/NCBI
15	Bollhalder L, Pfeil AM, Tomonaga Y and Schwenkglenks M: A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr. 32:213–223. 2013. View Article : Google Scholar : PubMed/NCBI
16	Chen QH, Yang Y, He HL, Xie JF, Cai SX, Liu AR, Wang HL and Qiu HB: The effect of glutamine therapy on outcomes in critically ill patients: A meta-analysis of randomized controlled trials. Crit Care. 18:R82014. View Article : Google Scholar : PubMed/NCBI
17	Crowther M, Avenell A and Culligan DJ: Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplant. 44:413–425. 2009. View Article : Google Scholar : PubMed/NCBI
18	Asrani V, Chang WK, Dong Z, Hardy G, Windsor JA and Petrov MS: Glutamine supplementation in acute pancreatitis: A meta-analysis of randomized controlled trials. Pancreatology. 13:468–474. 2013. View Article : Google Scholar : PubMed/NCBI
19	Zhong X, Liang CP and Gong S: Intravenous glutamine for severe acute pancreatitis: A meta-analysis. World J Crit Care Med. 2:4–8. 2013. View Article : Google Scholar : PubMed/NCBI
20	Tao KM, Li XQ, Yang LQ, Yu WF, Lu ZJ, Sun YM and Wu FX: Glutamine supplementation for critically ill adults. Cochrane Database Syst Rev. CD0100502014.PubMed/NCBI
21	Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR and Heyland DK: Parenteral glutamine supplementation in critical illness: A systematic review. Crit Care. 18:R762014. View Article : Google Scholar : PubMed/NCBI
22	Oldani M, Sandini M, Nespoli L, Coppola S, Bernasconi DP and Gianotti L: Glutamine supplementation in intensive care patients: A meta-analysis of randomized clinical trials. Medicine (Baltimore). 94:e13192015. View Article : Google Scholar : PubMed/NCBI
23	Yong L, Lu QP, Liu SH and Fan H: Efficacy of glutamine-enriched nutrition support for patients with severe acute pancreatitis: A meta-analysis. JPEN J Parenter Enteral Nutr. 40:83–94. 2016. View Article : Google Scholar : PubMed/NCBI
24	van Zanten AR, Dhaliwal R, Garrel D and Heyland DK: Enteral glutamine supplementation in critically ill patients: A systematic review and meta-analysis. Crit Care. 19:2942015. View Article : Google Scholar : PubMed/NCBI
25	Jiang Z, Jiang H and Fürst P: The impact of glutamine dipeptides on outcomes of surgical patients: Systematic review of randomized controlled trials from Europe and Asia. Clin Nutr Suppl. 1:17–23. 2004. View Article : Google Scholar
26	Zheng YM, Li F, Zhang MM and Wu XT: Glutamine dipeptide for parenteral nutrition in abdominal surgery: A meta-analysis of randomized controlled trials. World J Gastroenterol. 12:7537–7541. 2006. View Article : Google Scholar : PubMed/NCBI
27	Wang Y, Jiang ZM, Nolan MT, Jiang H, Han HR, Yu K, Li HL, Jie B and Liang XK: The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: A meta-analysis of randomized clinical trials. JPEN J Parenter Enteral Nutr. 34:521–529. 2010. View Article : Google Scholar : PubMed/NCBI
28	Yue C, Tian W, Wang W, Huang Q, Zhao R, Li Q and Li J: The impact of perioperative glutamine-supplemented parenteral nutrition on outcomes of patients undergoing abdominal surgery: A meta-analysis of randomized clinical trials. Am Surg. 79:506–513. 2013.PubMed/NCBI
29	Kang K, Shu XL, Zhang YS, Liu XL and Zhao J: Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: A meta-analysis of randomized controlled trials. Chinese Med J (Engl). 128:245–251. 2015. View Article : Google Scholar
30	Sandini M, Nespoli L, Oldani M, Bernasconi DP and Gianotti L: Effect of glutamine dipeptide supplementation on primary outcomes for elective major surgery: Systematic review and meta-analysis. Nutrients. 7:481–499. 2015. View Article : Google Scholar : PubMed/NCBI
31	Lin JJ, Chung XJ, Yang CY and Lau HL: A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn. Burns. 39:565–570. 2013. View Article : Google Scholar : PubMed/NCBI
32	Mottaghi A, Yeganeh MZ, Golzarand M, Jambarsang S and Mirmiran P: Efficacy of glutamine-enriched enteral feeding formulae in critically ill patients: A systematic review and meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr. 25:504–512. 2016.PubMed/NCBI
33	Heyland DK, Dhaliwal R, Drover JW, Gramlich L and Dodek P; Canadian Critical Care Clinical Practice Guidelines Committee, : Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 27:355–373. 2003. View Article : Google Scholar : PubMed/NCBI
34	Newsholme P: Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr. 131(9 Suppl): 2515S–2524S. 2001.PubMed/NCBI
35	Shu XL, Yu TT, Kang K and Zhao J: Effects of glutamine on markers of intestinal inflammatory response and mucosal permeability in abdominal surgery patients: A meta-analysis. Exp Ther Med. 12:3499–3506. 2016.PubMed/NCBI
36	Oliveira GP, Dias CM, Pelosi P and Rocco PR: Understanding the mechanisms of glutamine action in critically ill patients. An Acad Bras Cienc. 82:417–430. 2010. View Article : Google Scholar : PubMed/NCBI
37	Pradelli L, Povero M, Muscaritoli M and Eandi M: Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients. Eur J Clin Nutr. 69:546–551. 2015. View Article : Google Scholar : PubMed/NCBI
38	Rodas PC, Rooyackers O, Hebert C, Norberg Å and Wernerman J: Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond). 122:591–597. 2012. View Article : Google Scholar : PubMed/NCBI
39	Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, Etchells E, Ghali WA, Hébert P, Majumdar SR, et al: The Canadian adverse events study: The incidence of adverse events among hospital patients in Canada. CMAJ. 170:1678–1686. 2004. View Article : Google Scholar : PubMed/NCBI
40	Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, et al: Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 370:1198–1208. 2014. View Article : Google Scholar : PubMed/NCBI
41	Klevens RM, Edwards JR, Richards CL Jr..Horan TC, Gaynes RP, Pollock DA and Cardo DM: Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 122:160–166. 2007. View Article : Google Scholar : PubMed/NCBI
42	Heyland DK, Elke G, Cook D, Berger MM, Wischmeyer PE, Albert M, Muscedere J, Jones G and Day AG; Canadian Critical Care Trials Group, : Glutamine and antioxidants in the critically ill patient: A post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 39:401–409. 2015. View Article : Google Scholar : PubMed/NCBI
43	Vanek VW, Matarese LE, Robinson M, Sacks GS, Young LS and Kochevar M; Novel Nutrient Task Force, Parenteral Glutamine Workgroup; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors, : A.S.P.E.N. position paper: Parenteral nutrition glutamine supplementation. Nutr Clin Pract. 26:479–494. 2011. View Article : Google Scholar : PubMed/NCBI